Premium
Comparing Acute Mountain Sickness Definitions to Examine Differences in Systemic Inflammation
Author(s) -
Shah Karina,
DiMarco Kaitlyn,
Beasley Kara,
Speros Julia,
Elliott Jonathan,
Laurie Steven,
Duke Joseph,
Goodman Randall,
Futral Eben,
Hawn Jerold,
Roach Robert,
Lovering Andrew
Publication year - 2021
Publication title -
the faseb journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.709
H-Index - 277
eISSN - 1530-6860
pISSN - 0892-6638
DOI - 10.1096/fasebj.2021.35.s1.03330
Subject(s) - medicine , hypoxia (environmental) , proinflammatory cytokine , systemic inflammation , inflammation , oxygen , chemistry , organic chemistry
Acute mountain sickness (AMS) occurs when individuals rapidly ascend to high altitudes, but its exact cause remains unknown. Additionally, AMS is assessed using a subjective questionnaire with a variety of criteria used for diagnosis so there is no precise, objective method for determining if a subject has AMS. Hypoxia, or low oxygen, at altitude results in a proinflammatory state and AMS is associated with systemic inflammation as determined by elevated plasma levels of some cytokines. Thus, we wanted to determine if the association between AMS and inflammation was altered based on how AMS was defined. To examine this, 17 women and 17 men were exposed to 10 hours of normobaric hypoxia (11.5% O 2 ) simulating 15600 feet. Blood samples taken before and at 10 hours of hypoxia were assayed for 13 inflammatory cytokines. AMS was defined by the following definitions: 1) Lake Louise Questionnaire (LLQ) score ≥3 and a headache score ≥1 at the 10‐hour time point, 2) maximum LLQ score ≥3 and a maximum headache score of ≥1, 3) maximum LLQ score ≥3 and a maximum Environmental Symptoms Questionnaire (ESQ) score of 0.7 or maximum LLQ ≥3, a maximum headache score ≥2, and a maximum ESQ ≥0.4, 4) maximum LLQ ≥3, 5) LLQ score ≥3 at the 10‐hour time point. We found that Interleukin (IL) 8 significantly increased in AMS‐ but not AMS+ participants regardless of AMS definition. Additionally, AMS‐ but not AMS+ participants significantly increased IL‐1β and IL‐33 concentration from baseline to 10 hours of hypoxia under only three out of the five definitions (#1, #3 & #5 above for IL‐1β and #3, #4, & #5 above for IL‐33). Furthermore, the change in IL‐1β concentration after 10 hours of hypoxia was significantly different between AMS‐ and AMS+ participants under definition #3 above. These data suggest that how AMS is defined may influence whether or not there are differences in circulating inflammatory cytokines between those with and without AMS. Therefore, the relationship between systemic inflammation and AMS may be more complex than previously thought.